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AbstrAct:
Atrioventricular (AV) block is defined as a delay or interruption in the transmission of an impulse 
from the atria to the ventricles due to an anatomical or functional impairment in the conduction 
system. The conduction disturbance can be transient or permanent. In third degree AV block, 
also referred to as complete heart block, there is complete dissociation of the atrial and ventricular 
activity. Atrioventricular block is considered to be “congenital” when it occurs spontaneously in 
a fetus or young child. In children, the most common cause of permanent acquired complete AV 
block is surgery for congenital heart disease. Injury to fetal conduction tissues caused by transpla-
cental exposure to maternal autoantibodies related to systemic lupus erythematosus or Sjogren’s 
syndrome is responsible for 60 to 90 percent of cases of congenital CHB overall1-3. As many as 
40 percent of cases of congenital CHB do not present until later in childhood (mean age five to six 
years). Only rarely do these patients (5 percent) have proven autoimmune etiology. The increased 
risk of sudden death is associated with the onset of deep bradycardia or ventricular arrhythmia. 
A routine electrocardiogram is sufficient to diagnose the disease. A 15-year-old girl has been 
examined at the emergency pediatric outpatient clinic of the University Hospital Centre “Sestre 
Milosrdnice” for recurrent episodes of presyncope. Physical examination revealed no major devia-
tions other than bradycardia. Her vital signs were within the reference range, with the exception of 
a pulse of about 44 beats per minute. The electrocardiogram showed atrioventricular dissociation 
consistent with third degree atrioventricular block. The echocardiogram showed a structurally 
normal heart except for sinus bradycardia. The girl underwent permanent epicardial pacemaker 
implantation after which there were no symptoms. 
Keywords: complete heart block, CHB, complete atrioventricular block, third degree atrioven-
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Sažetak:
AtrioventrikulArni blok srcA trećeg stupnjA u djece
Atrioventrikularni (AV) blok je definiran kao kašnjenje ili prekid u prijenosu impulsa iz atrija u ven-
trikule zbog anatomskih ili funkcionalnih oštećenja u provodnom sustavu srca. Poremećaj provodl-
jivosti može biti prolazan ili trajan. U AV bloku trećeg stupnja, koji se još naziva i kompletni srčani 
blok, dolazi do potpune disocijacije atrijske i ventrikularne aktivnosti. Atrioventrikularni blok se 
smatra “kongenitalnim” kada se pojavljuje spontano kod fetusa ili malog djeteta. Stečeni permanent-
ni kompletni AV blok kod djece najčešće je posljedica kirurške korekcije prirođenih srčanih grešaka. 
Ozljeda fetalnog provodnog srčanog tkiva uzrokovana transplacentarnom izloženošću majčinim 
autoantitijelama povezanim sa sistemskim eritematoznim lupusom ili Sjogrenovim sindromom 
odgovorna je za 60 do 90 posto slučajeva kongenitalnog srčanog bloka1-3. Čak 40 posto slučajeva 
kongenitalnog srčanog bloka se javlja kasnije u djetinjstvu (prosječna dob od pet do šest godina). 
Od navedenih samo rijetki pacijenti (5 posto) imaju dokazanu autoimunu etiologiju. Povećan rizik 
iznenadne smrti se veže uz nastup duboke bradikardije ili ventrikulske aritmije. Za dijagnozu bolesti 
je dovoljan rutinski elektrokardiogram. Djevojčica od 15 godina je pregledana u hitnoj pedijatrijskoj 
ambulanti kliničkog bolničkog centra “Sestre Milosrdnice”, zbog ponavljajućih epizoda presinkopa. 
Tjelesnim pregledom se nije utvrdilo većih odstupanja, osim bradikardije. Njeni vitalni znakovi su 
bili unutar referentnog raspona, s izuzetkom pulsa koji je iznosio oko 44 otkucaja u minuti. Elektro-
kardiogram je pokazao atrioventrikularnu disocijaciju u skladu s atrioventrikularnim blokom trećeg 
stupnja. Ehokardiogram je izuzev sinusne bradikardije pokazao strukturno normalno srce. Djevojka 
je podvrgnuta ugradnji trajnog epikardijalnog pacmakera nakon čega više nije imala simptoma i 
tegoba u budućnosti. 
ključne riječi: kompletni srčani blok, kompletni atrioventrikularni blok, atrioventrikularni blok 
3. stupnja, kongenitalni atrioventrikularni blok, stečeni atrioventrikularni blok, djeca, bradikardija
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CaSe preSentation
A 15-year-old girl was referred to pediatric emergency department 
outpatient clinic of the University Hospital Centre “Sestre Milosrd-
nice” due to a recurrence of an episode of presyncope back in 3 days. 
For the past 11 months, there has been a daily feeling of shortness 
of breath. Three days before admission, she felt weak, flushed before 
her eyes, faded. The day before her admission, her eyes turned black 
again at school and she collapsed. There were no convulsive elements 
and she did not lose consciousness. After the examination, her vital 
signs were within the reference range. The heart action was brady-
cardic, a systolic murmur 1/6 heard over Erb’s point was observed. 
The heart rate received was a bio variable and ranged from 42-60/
min. The electrocardiogram showed atrioventricular dissociation 
consistent with third degree atrioventricular block. A 24-h holter 
was made, recording an average rhythm of 44/min (daily 51/min, 
night 36/min). The minimum rhythm was reduced by 28/min, the 
maximum by 109/min. RR breaks of up to 3.5 s with rare isolated 
VES were noted. An echocardiographically discontinuation of the 
continuous interatrial septum at the level of the oval fossa 2 mm 
with an L-R flow of 1.06 m/s, hemodynamically insignificant. Spi-
rometry was neat, salbutamol test negative. She had normal electro-
lytes, renal and liver function, full blood count and random blood 
sugar test results. Anti-SSA/Ro and anti-SSB/La, anti-double-strand-
ed deoxyribonucleic acid (dsDNA), antinuclear antibodies (ANA) 
and antineutrophil cytoplasmic antibodies (ANCA) autoantibodies. 
were negative. There were no heart diseases in the family. The child 
underwent implantation of a permanent epicardial pacemaker after 
there were no symptoms. 
DiSCuSSion
The atrioventricular (AV) block is defined as the interruption or de-
lay in the transfer of impulses from the atrium to the ventricles due 
to an anatomical or functional disorder in the conduction cardiac 
system. The atrioventricular block is considered “congenital” when 
it occurs spontaneously in a fetus or child. Congenital complete 
heart block (CHB) was first described in 1901 by Morquio, who 
also noted familial occurrence and association with Stokes-Adams 
attacks and death4. The presence of fetal bradycardia (40 to 80 beats 
per minute) as a manifestation of CHB was first noted in 1921 and 
is the initial sign of this disorder in many cases5. The incidence of 
congenital CHB is estimated from 1 in 15,000 to 1 and 22,000 
newborns6,7. In children, the most common cause of permanently 
acquired complete AV block is surgery for congenital heart disease. 
Fetal conduction injury caused by transplacental transfer of ma-
ternal antibodies to patients with systemic lupus erythematosus or 
Sjogren’s syndrome is thought to be responsible for 60-90 percent 
of the cause of congenital CHB.1-3 Among women with anti-Ro 
/ SSA and / or anti-La / SSB antibodies, fetal / neonatal CHB 
occurs in approximately 2 percent of pregnancies8,9. 40 percent of 
all congenital heart block cases are not clinically presented until 
later in childhood (average between 5 and 7 years)3. Only rarely 
do these patients (5 percent) have proven autoimmune etiology 
3. The etiology of complete heart block in children includes the 
following: autoimmune diseases, structural abnormalities due to 
congenital heart defects (eg congenitally corrected transposition of 
large blood vessels, defects of endocardial pads), idiopathic familial 
congenital complete heart block, or the consequence of overfeeding 
myocardial myocardial surgery10. Congenitally impaired AV nodal 
function may also be observed in some simple cases of atrial septal 
defect among patients with Holt-Oram syndrome, an autosomal 
dominant disorder causing cardiac and upper-limb abnormalities 
that causes a mutation on the TBX5 gene11. The manifestation 
of congenital CHB varies depending on the age of presentation, 
causes, ventricular frequency, and ventricular function. Patients with 
autoimmune etiology present earlier than those with other causes 
of CHB12. Clinically, CHB is presented differently at a certain age. 
Regarding neonatal age, the primary presentation of infants with 
congenital heart block is a slow heart rate below 100 beats per 
minute. Such newborns may appear pale due to decreased cardiac 
output. Signs of congestive heart failure (eg, crackles on lung exam-
ination, elevated jugular venous pulsations, peripheral edema, etc) 
may also occur. First or second degree AV block found in infants at 
birth can progress to CHB and should be followed carefully13,-16. 40 
percent of patients with congenital CHB present later in childhood. 
The primary finding in these children is a slow heart rate with or 
without symptoms, including poorer effort tolerance, presyncope or 
syncope (Stokes-Adams seizures). Sudden death has also been rarely 
described17-19. 
A routine electrocardiogram is sufficient to diagnose the disease 
and echocardiography reveals an associated structural heart failure 
or cardiomyopathy. Holter monitoring and load tests assess the 
basal frequency of the downstream rhythm of the conductor and 
the possibility of its increase in various physiological requirements, 
tendency for deep bradycardia and arrhythmias. The therapeutic 
approach for prenatal diagnosed congenital CHB is largely expect-
ant. If fetal hydrops or other signs of fetal distress develop, there is a 
possibility of early delivery or emergency pacing. If CHB diagnosed 
in utero is caused by transplacental transfer of maternal antibodies 
to patients with systemic lupus erythematosus or Sjogren’s syn-
drome, corticosteroid therapy should be considered depending on 
the time of diagnosis. If the heart block is already complete and 
has been present for more than three weeks, it is considered that an 
attempt at reversing this complete heart block is futile, and therefore 
serial echocardiographic and obstetrical follow-up, but no therapy 
is recommended.  If, however, the third degree heart block has been 
recently diagnosed, a therapeutic course of dexamethasone 4 mg. 
orally once a day for a period of six weeks may be attempted. For in-
fants and children who are presented later, the therapeutic approach 
depends on the presence or absence of symptoms. Patients with 
adequate ventricular frequency and no symptoms may be followed, 
while symptomatic patients (usually those with a slower ventricular 
rhythm) need a permanent pacemaker20. Pacemaker implantation 
was recommended (class I) or felt to be reasonable (class IIa) for 
patients with congenital CHB and the following characteristics: 
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symptomatic bradycardia or low cardiac output (class I), wide QRS 
escape rhythm, complex ventricular ectopy, or ventricular dys-
function (class I), infants with normal anatomy and a ventricular 
rate of less than 55 beats per minute (class I), infants with other 
structural congenital heart disease and a ventricular rate of less 
than 70 beats per minute (class I), children beyond the first year of 
life with an average heart rate of less than 50 beats per minute, or 
abrupt pauses two to three times the basic RR cycle length (class 
IIa). CHB, which is presented prenatally, and is mainly due to 
maternal antibodies, is associated with a higher mortality rate10,21,22. 
The outcome of patients diagnosed in the infant is better than the 
outcome of those diagnosed in utero. Children with CHB who are 
asymptomatic generally remain asymptomatic until later childhood, 
adolescence, or adulthood6,23. Prognosis is generally excellent among 
infants and those diagnosed later in childhood10. However, exercise 
limitation and even mortality in childhood are not negligible24-26. 
Even patients who have been asymptomatic throughout childhood 
are at increased risk of sudden death. In a review of 102 patients 
who were without symptoms through age 15, 27 (26 percent) had 
a subsequent syncopal episode, eight of which were fatal18. The 
ventricular rate tends to fall slowly with age18. To compensate for 
the slow heart rate, the heart enlarges to produce a higher stroke 
volume; in some cases, this may lead to voltage criteria for left 
ventricular enlargement and nonspecific ST-T wave changes27 as 
well as to heart failure28,29. In general, the prognosis of the following 
pacemaker implantation is excellent15,30,31. However, a significant 
number of patients (5 to 11 percent) develop heart failure over the 
long term, even if a pacemaker is inserted28,29. 
ConCluSion
The most common etiologies of CHB include the following: idio-
pathic familial congenital CHB, autoimmune antibodies, structural 
heart abnormalities due to congenital heart disease (eg, congenitally 
corrected transposition of the great arteries, endocardial cushion 
defects), consequence of myocarditis or mechanical trauma from 
surgical or transcatheter interventions. Symptoms of children 
with complete AV block and structurally normal heart range from 
unbearable physical exertion, syncope to complete absence of symp-
toms. Treatment of patients with low cardiac output syndrome or 
at risk of sudden death is performed by installing a permanent elec-
trostimulator. Despite its infrequency and life-threatening potential, 
patients with congenital complete heart block have an excellent 
survival rate with timely diagnosis and intervention. 
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